Napo Pharmaceuticals
Crofelemer
A proprietary gastro-intestinal compound in clinical development for four distinct product indications
people
Board of Directors
Thomas Van Dyck
Non-Executive Director
Thomas Van Dyck specialises in Socially Responsible Investing (SRI) and is a pioneer in the industry. Currently he is a Senior Vice-President with the SRI Wealth Management Group at RBC Dain Rauscher, one of the leading consulting teams on SRI in the country. Previously, he led the Philanthropic and Social Investment Consulting at Piper Jaffray & Company and was a co-founder of Progressive Asset Management. He has authored numerous articles on SRI and is quoted often in national and local media outlets. His passion and quantitative work towards not compromising performance while applying qualitative screens to investment portfolios helped CALPERS in adapting Green Wave in 2004. In 2005 to 2006, he led Piper Jaffray to create the first Clean Tech Private Equity fund of fund in the country. He earned a B.A. in Political Science from Duke and also completed the Certified Investment Management Analyst Program at the Wharton School at the University of Pennsylvania.
